collapse the Rx/generic Rx market entirely. capture as much as of US fishoil market as possible.
leave the generic Rx API purveyors to try to get generic Rxs written by prescribers (and covered by 3rd party payors) while a consumer can walk into a pharmacy, grocery, etc and buy vascepa off the shelf.
of course, this model trades off lower product cost for higher sales volume.